California earmarks $50 million for early stem cell trials
This article was originally published in Scrip
Executive Summary
The California Institute for Regenerative Medicine (CIRM), the state's stem cell research funding agency, has earmarked $50 million through its Targeted Clinical Development Awards to fund early clinical development with the aim of speeding up the development timeline of new stem cell therapies.